enGene Holdings Inc. Cash Flow Statement

Cash Flow Statement Oct2022 Oct2023 Oct2024 Oct2025
Operating Activities
Net Income -24.46M-99.92M-55.14M-117.30M
Depreciation and Depletion 0.24M0.17M0.32M0.51M
Share-based Compensation 0.12M3.45M5.32M9.65M
Gains from Investment Securities 3.33M-10.85M1.90M6.35M
Cash from Operations -17.59M-24.74M-48.28M-99.24M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 1.80M-0.23M3.70M
Depreciation & Amortization (CF) 0.20M0.20M0.30M0.50M
Change in Working Capital
Change in Account Payables -0.20M0.37M0.47M4.94M
Change in Accured Expenses 2.34M0.87M5.22M3.13M
Other Working Capital Changes 0.11M0.75M7.57M-1.99M
Investing Activities
Capital Expenditures 0.15M0.32M0.93M1.49M
Change in Acquisitions & Divestments 137.19M
Cash from Investing Activities -0.15M-0.32M-125.95M-25.14M
Financing Activities
Other financing activities 0.39M0.58M
Cash from Financing Activities 27.97M86.15M265.72M1.52M
Additional items
Exchange Rate Effect -0.81M0.00M0.00M0.00M
Change in Cash 9.42M61.09M91.48M-122.85M
Beginning Cash Balance -9.42M-61.09M-91.48M122.85M
Free Cash Flow -17.75M-25.06M-49.21M-100.72M
Net Cash Flow 10.22M61.09M91.48M-122.85M